Active, not recruitingPhase 2NCT01878617
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Amar Gajjar, MDSt. Jude Children's Research Hospital
- Intervention
- Craniospinal Irradiation with boost to the primary tumor site(radiation)
- Enrollment
- 660 enrolled
- Eligibility
- 3-39 years · All sexes
- Timeline
- 2013 – 2031
Study locations (23)
- Lucille Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States
- Rady Children's Hospital, San Diego, California, United States
- Yale University, New Haven, Connecticut, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida, Gainesville, Florida, United States
- Arnold Palmer Hospital for Children, Orlando, Florida, United States
- Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
- Duke Children's Hospital and Health Center, Durham, North Carolina, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- Cook Children's Medical Center, Fort Worth, Texas, United States
- Texas Children's Cancer Center, Houston, Texas, United States
- Sydney Children's Hospital, Randwick, New South Wales, Australia
- +8 more locations on ClinicalTrials.gov
Collaborators
Genentech, Inc. · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01878617 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS